References
- Andersson B., Berggren M., Moldeus P. Conjugation of various drugs in isolated hepatocytes. Drug Metabolism and Disposition 1978; 6: 611–619
- Caldwell J. Conjugation reactions. Concepts in Drug Metabolism, part A, P. Jenner, B. Testa, 1980; volume 10, of Drugs and The Pharmaceutical Sciences edited by Swarbrick, J. (New York and Basel: Marcel Dekker Inc.), pp. 211–250
- Daly J. W., Jerina D. M., Witkop B. Arene oxides and the NIH shift: the metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia 1972; 28: 1129–1149
- Fayz S., Cherry W. F., Dawson J. R., Mulder G. S., Pang S. K. Inhibition of acetaminophen sulfation by 2,6-dichloro-4-nitrophenol in the perfused rat liver preparation. Lack of a compensatory increase of glucuronidation. Drug Metabolism and Disposition 1984; 12: 323–329
- Frincke J. M., Henderson G. L. The major metabolite of fentanyl in the horse. Drug Metabolism and Disposition 1980; 8: 425–427
- Goromaru T., Matsuura H., Furuta T., Baba S., Yoshimura N., Miyawaki T., Sameshima T. Identification of fentanyl metabolites in rat urine by gas chromatography-mass spectrometry with stable-isotope tracers. Drug Metabolism and Disposition 1982; 10: 542–546
- Goromaru T., Katashima M., Matsuura H., Yoshimura N. Metabolism of fentanyl in isolated hepatocytes from rat and guinea pig. Chemical and Pharmaceutical Bulletin 1985; 33: 3922–3928
- Heykants J., Meuldermans W., Michiels M., Hekman P., Hoerig C. Die vergleichende Pharmakokinetik vom Alfentanil bei Tier und Mensch. Alfentanil, A. Doenicke. Springer-Verlag, Berlin, Heidelberg, New York, Tokyo 1986; 16–25
- Kato R. Sex-related differences in drug metabolism. Drug Metabolism Reviews 1974; 3: 1–32
- Lehmann K. A., Weski C., Hunger L., Heinrich C., Daub D. Biotransformation von Fentanyl. II. Akute Arzneimittelinteraktionen-Untersuchungen bei Ratte und Mensch. Anaesthesist 1982; 31: 221–227
- Maruyama Y., Hosoya E. Studies on the fate of fentanyl. Keio Journal of Medicine 1969; 18: 59–70
- Mather L. E. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clinical Pharmacokinetics 1983; 8: 422–446
- Meuldermans W., Hendrickx J., Lauwers W., Hurkmans R., Thijssen J., Timmerman P., Woestenborghs R., Heykants J. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs. Drug Metabolism and Disposition 1987, in press
- Moldeus P., Hogberg J., Orrenius S. Isolation and use of liver cells. Methods in Enzymology 1978; 52: 60–71
- Reese J. A., Byard J. L. Isolation and culture of adult hepatocytes from liver biopsies. In vitro 1981; 17: 935–940
- Seglen P. O. Preparation of rat liver cells. I. Effect of Ca2+ on enzymatic dispersion of isolated, perfused liver. Experimental Cell Research 1972; 74: 450–454
- Seglen P. O. Preparation of rat liver cells, III. Enzymatic requirements for tissue dispersion. Experimental Cell Research 1973; 82: 391–398
- Strom S. C., Jirtle R. L., Jones R. S., Novicki D. L., Rosenberg M. R., Novotny A., Irons G., McLain J. R., Michalopoulos. Isolation, culture and transplantation of human hepatocytes. Journal of the National Cancer Institute 1982; 68: 771–778
- Vanden Bussche G., Noorduin H. Alfentanil and sufentanil: towards a more specific use of narcotics in anesthesia. Drug Development Research 1986; 8: 341–346
- Van Wijngaarden I., Soudijn W. The metabolism and excretion of the analgesic fentanyl (R 4263) by Wistar rats. Life Sciences 1968; 7: 1239–1244
- Waxman D. J. Rat hepatic cytochrome P-450 isoenzyme 2c. Identification as a male-specific, developmentally induced steroid 16x-hydroxylase and comparison to a female-specific cytochrome P-450 isoenzyme. Journal of Biological Chemistry 1984; 259: 15481–15490